Literature DB >> 10085148

Transcriptional activation of the glucose transporter GLUT1 in ventricular cardiac myocytes by hypertrophic agonists.

C Montessuit1, A Thorburn.   

Abstract

Myocardial hypertrophy is associated with increased basal glucose metabolism. Basal glucose transport into cardiac myocytes is mediated by the GLUT1 isoform of glucose transporters, whereas the GLUT4 isoform is responsible for regulatable glucose transport. Treatment of neonatal cardiac myocytes with the hypertrophic agonist 12-O-tetradecanoylphorbol-13-acetate or phenylephrine increased expression of Glut1 mRNA relative to Glut4 mRNA. To study the transcriptional regulation of GLUT1 expression, myocytes were transfected with luciferase reporter constructs under the control of the Glut1 promoter. Stimulation of the cells with 12-O-tetradecanoylphorbol-13-acetate or phenylephrine induced transcription from the Glut1 promoter, which was inhibited by cotransfection with the mitogen-activated protein kinase phosphatases CL100 and MKP-3. Cotransfection of the myocytes with constitutively active versions of Ras and MEK1 or an estrogen-inducible version of Raf1 also stimulated transcription from the Glut1 promoter. Hypertrophic induction of the Glut1 promoter was also partially sensitive to inhibition of the phosphatidylinositol 3-kinase pathway and was strongly inhibited by cotransfection with dominant-negative Ras. Thus, Ras activation and pathways downstream of Ras mediate induction of the Glut1 promoter during myocardial hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085148     DOI: 10.1074/jbc.274.13.9006

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Cellular and molecular regulation of cardiac glucose transport.

Authors:  L H Young; D L Coven; R R Russell
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

2.  O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.

Authors:  Heberty T Facundo; Robert E Brainard; Lewis J Watson; Gladys A Ngoh; Tariq Hamid; Sumanth D Prabhu; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-09       Impact factor: 4.733

Review 3.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

4.  Insulin Signaling Via Progesterone-Regulated Insulin Receptor Substrate 2 is Critical for Human Uterine Decidualization.

Authors:  Alison M Neff; Jie Yu; Robert N Taylor; Indrani C Bagchi; Milan K Bagchi
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

5.  Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.

Authors:  E D Abel; H C Kaulbach; R Tian; J C Hopkins; J Duffy; T Doetschman; T Minnemann; M E Boers; E Hadro; C Oberste-Berghaus; W Quist; B B Lowell; J S Ingwall; B B Kahn
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

6.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

Authors:  Darrell D Belke; Sandrine Betuing; Martin J Tuttle; Christophe Graveleau; Martin E Young; Mark Pham; Dongfang Zhang; Robert C Cooksey; Donald A McClain; Sheldon E Litwin; Heinrich Taegtmeyer; David Severson; C Ronald Kahn; E Dale Abel
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 7.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

8.  Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells).

Authors:  C Alfarano; L Sartiani; C Nediani; E Mannucci; A Mugelli; E Cerbai; L Raimondi
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

9.  Phosphorylation or Mutation of the ERK2 Activation Loop Alters Oligonucleotide Binding.

Authors:  Andrea C McReynolds; Aroon S Karra; Yan Li; Elias Daniel Lopez; Adrian G Turjanski; Elhadji Dioum; Kristina Lorenz; Elma Zaganjor; Steve Stippec; Kathleen McGlynn; Svetlana Earnest; Melanie H Cobb
Journal:  Biochemistry       Date:  2016-03-16       Impact factor: 3.162

10.  Cardioprotective effect of ritonavir, an antiviral drug, in isoproterenol induced myocardial necrosis: a new therapeutic implication.

Authors:  Prachi Gupta; Abhinav Kanwal; Uday Kumar Putcha; Yogesh Bulani; Bhavesh Sojitra; Tarak Nath Khatua; Madhusudana Kuncha; Sanjay Kumar Banerjee
Journal:  J Transl Med       Date:  2013-03-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.